271 related articles for article (PubMed ID: 17189348)
1. Regulation of lymphatic capillary regeneration by interstitial flow in skin.
Goldman J; Conley KA; Raehl A; Bondy DM; Pytowski B; Swartz MA; Rutkowski JM; Jaroch DB; Ongstad EL
Am J Physiol Heart Circ Physiol; 2007 May; 292(5):H2176-83. PubMed ID: 17189348
[TBL] [Abstract][Full Text] [Related]
2. The resolution of lymphedema by interstitial flow in the mouse tail skin.
Uzarski J; Drelles MB; Gibbs SE; Ongstad EL; Goral JC; McKeown KK; Raehl AM; Roberts MA; Pytowski B; Smith MR; Goldman J
Am J Physiol Heart Circ Physiol; 2008 Mar; 294(3):H1326-34. PubMed ID: 18203849
[TBL] [Abstract][Full Text] [Related]
3. Characterization of lymphangiogenesis in a model of adult skin regeneration.
Rutkowski JM; Boardman KC; Swartz MA
Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1402-10. PubMed ID: 16648194
[TBL] [Abstract][Full Text] [Related]
4. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody.
Pytowski B; Goldman J; Persaud K; Wu Y; Witte L; Hicklin DJ; Skobe M; Boardman KC; Swartz MA
J Natl Cancer Inst; 2005 Jan; 97(1):14-21. PubMed ID: 15632376
[TBL] [Abstract][Full Text] [Related]
5. Extracorporeal shock wave therapy combined with vascular endothelial growth factor-C hydrogel for lymphangiogenesis.
Kim IG; Lee JY; Lee DS; Kwon JY; Hwang JH
J Vasc Res; 2013; 50(2):124-33. PubMed ID: 23208012
[TBL] [Abstract][Full Text] [Related]
6. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
Lohela M; Heloterä H; Haiko P; Dumont DJ; Alitalo K
Am J Pathol; 2008 Dec; 173(6):1891-901. PubMed ID: 18988807
[TBL] [Abstract][Full Text] [Related]
7. Differential mRNA and tissue expression of lymphangiogenic growth factors (VEGF-C and -D) and their receptor (VEGFR-3) during tail regeneration in a gecko.
Blacker HA; Orgeig S
J Comp Physiol B; 2012 Jan; 182(1):109-26. PubMed ID: 21800152
[TBL] [Abstract][Full Text] [Related]
8. VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study.
Visuri MT; Honkonen KM; Hartiala P; Tervala TV; Halonen PJ; Junkkari H; Knuutinen N; Ylä-Herttuala S; Alitalo KK; Saarikko AM
Angiogenesis; 2015 Jul; 18(3):313-26. PubMed ID: 26018927
[TBL] [Abstract][Full Text] [Related]
9. Lymphangiogenesis-independent resolution of experimental edema.
Ongstad EL; Bouta EM; Roberts JE; Uzarski JS; Gibbs SE; Sabel MS; Cimmino VM; Roberts MA; Goldman J
Am J Physiol Heart Circ Physiol; 2010 Jul; 299(1):H46-54. PubMed ID: 20207821
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of VEGF-C causes transient lymphatic hyperplasia but not increased lymphangiogenesis in regenerating skin.
Goldman J; Le TX; Skobe M; Swartz MA
Circ Res; 2005 Jun; 96(11):1193-9. PubMed ID: 15890974
[TBL] [Abstract][Full Text] [Related]
11. Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation.
Karpanen T; Wirzenius M; Mäkinen T; Veikkola T; Haisma HJ; Achen MG; Stacker SA; Pytowski B; Ylä-Herttuala S; Alitalo K
Am J Pathol; 2006 Aug; 169(2):708-18. PubMed ID: 16877368
[TBL] [Abstract][Full Text] [Related]
12. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
13. Cooperative and redundant roles of VEGFR-2 and VEGFR-3 signaling in adult lymphangiogenesis.
Goldman J; Rutkowski JM; Shields JD; Pasquier MC; Cui Y; Schmökel HG; Willey S; Hicklin DJ; Pytowski B; Swartz MA
FASEB J; 2007 Apr; 21(4):1003-12. PubMed ID: 17210781
[TBL] [Abstract][Full Text] [Related]
14. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
[TBL] [Abstract][Full Text] [Related]
15. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
16. The VEGF-C/VEGFR3 signaling pathway contributes to resolving chronic skin inflammation by activating lymphatic vessel function.
Hagura A; Asai J; Maruyama K; Takenaka H; Kinoshita S; Katoh N
J Dermatol Sci; 2014 Feb; 73(2):135-41. PubMed ID: 24252749
[TBL] [Abstract][Full Text] [Related]
17. Functional Importance of a Proteoglycan Coreceptor in Pathologic Lymphangiogenesis.
Johns SC; Yin X; Jeltsch M; Bishop JR; Schuksz M; El Ghazal R; Wilcox-Adelman SA; Alitalo K; Fuster MM
Circ Res; 2016 Jul; 119(2):210-21. PubMed ID: 27225479
[TBL] [Abstract][Full Text] [Related]
18. Expression of VEGFR-3 and 5'-nase in regenerating lymphatic vessels of the cutaneous wound healing.
Ji RC; Miura M; Qu P; Kato S
Microsc Res Tech; 2004 Jun; 64(3):279-86. PubMed ID: 15452895
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor-C stimulates the lymphatic pump by a VEGF receptor-3-dependent mechanism.
Breslin JW; Gaudreault N; Watson KD; Reynoso R; Yuan SY; Wu MH
Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H709-18. PubMed ID: 17400713
[TBL] [Abstract][Full Text] [Related]
20. Activation of the VEGFR-3 pathway by VEGF-C attenuates UVB-induced edema formation and skin inflammation by promoting lymphangiogenesis.
Kajiya K; Sawane M; Huggenberger R; Detmar M
J Invest Dermatol; 2009 May; 129(5):1292-8. PubMed ID: 19005491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
